How should patient decision aids for schizophrenia treatment be designed? - A scoping review
Schizophrenia Research · 2023-05 · 255 · 261-273
DOI: 10.1016/j.schres.2023.03.025 ↗Kurz gefasst
Scoping Review in der Zeitschrift Schizophrenia Research, 2023-05. Verfasst von Katharina Müller und 5 weiteren Autor:innen. Beteiligte Einrichtung: kbo-Isar-Amper-Klinikum München, Munich, Germany; Department of Psychiatry and Psychotherapy, School of Medicine, Technical University of Munich, Mun…. Hauptthemen laut MEDLINE: Decision Support Techniques, Schizophrenia. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 43 Literaturangaben.
Abstract (Originalsprache)
Despite the clear rationale for applying shared decision-making in the context of the preference sensitive decision for or against antipsychotics and the upswing of patient decision aids (pDAs) to support this process, there is still a lack of knowledge regarding which key features are crucial for pDAs in schizophrenia treatment. A scoping review according to the PRISMA-SRc was conducted to inform on crucial key features and quality indicators. The review focussed on the following seven aspects for investigating pDAs: (1) Types of decision aids, (2) Values, (3) Decision Guidance, (4) Output of the decision aid, (5) Target group, (6) Effectiveness according to publication and (7) Decision aid evaluation. Eleven studies which addressed six unique decision aids met the eligibility criteria. There were major differences in the design as well as in the development of the decision aids. Three aspects emerged that should be given special consideration in the design of such tools for antipsychotics: the evidence used by the decision aid, the algorithm for translating evidence into a decision aid and finally the presentation of the evidence. We recommend the use of data with a high level of evidence and to combine it with individualized treatment by taking into account patient preferences and previous experiences as well as comparing them with clinical assessments. Fully computerized decision aids that use complicated algorithms, for example, by merging treatment effects with patient characteristics to suggest an appropriate treatment at the end, tend to be paternalistic and thus not appropriate for SDM, in our view. In addition, possible cognitive deficits need to be considered when presenting the output of decision aids for antipsychotics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- kbo-Isar-Amper-Klinikum München, Munich, Germany; Department of Psychiatry and Psychotherapy, School of Medicine, Technical University of Munich, Munich, Germany.
- Department of Psychiatry and Psychotherapy, School of Medicine, Technical University of Munich, Munich, Germany; Schön Klinik Bad Aibling Harthausen, Bad Aibling, Germany.
- Department of Clinical and Experimental Medicine, Institute of Psychiatry, University of Catania, Catania, Italy.
- Department of Psychiatry and Psychotherapy, School of Medicine, Technical University of Munich, Munich, Germany.
- Department of Psychiatry and Psychotherapy, School of Medicine, Technical University of Munich, Munich, Germany. Electronic address: stefan.leucht@tum.de.
- Department of Psychiatry and Psychotherapy, School of Medicine, Technical University of Munich, Munich, Germany; Bezirkskrankenhaus Mainkofen, Deggendorf, Germany.
Zitieren
APA
Müller, K., Schuster, F., Rodolico, A., Siafis, S., Leucht, S., & Hamann, J. (2023). How should patient decision aids for schizophrenia treatment be designed? - A scoping review. Schizophrenia Research, 255, 261-273. https://doi.org/10.1016/j.schres.2023.03.025
Vancouver
Müller K, Schuster F, Rodolico A, Siafis S, Leucht S, Hamann J. How should patient decision aids for schizophrenia treatment be designed? - A scoping review. Schizophrenia Research. 2023;255:261-273. doi:10.1016/j.schres.2023.03.025
BibTeX
@article{Mller2023,
author = {Müller, Katharina and Schuster, Florian and Rodolico, Alessandro and Siafis, Spyridon and Leucht, Stefan and Hamann, Johannes},
title = {How should patient decision aids for schizophrenia treatment be designed? - A scoping review},
journal = {Schizophrenia Research},
year = {2023},
volume = {255},
pages = {261--273},
doi = {10.1016/j.schres.2023.03.025}
}
EUVIMED